Novo Nordisk A/S
NVO · Large Cap · NYSE · Healthcare · Drug Manufacturers - General
$46.63−$0.89 (-1.86%)
Free research brief
Get the full brief on NVO
Free to track. No card required.
Where NVO sits today
Price, momentum, and the numbers behind the story.
RSI (14)
49.1Neutral
03070100
Overall score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$40.23
Median target
$45.2
Current price
$46.63
Highest
$64.11
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 19% below avg
15.18x
Price / FCF
Strong · Cash flow supports price
17.44x
EV / EBITDA
Strong · Earnings support price
8.30x
ROIC
Strong · Excellent capital returns
39.2%
ROE
Favorable · 59.8% - strong capital efficiency
59.8%
Debt / equity
Favorable · 0.63 - strong leverage
0.63x
⚠ Things to watch
Current ratio
Weak · Low cash for bills
0.87x
How it stacks up against its peers
NVO against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $155.92B | 11.4 | +5.6% | 52 |
 | $10.51B | 20.0 | +19.7% | 78 |
 | $33.17B | 34.7 | +15.5% | 78 |
 | $4.12B | 12.4 | +13.5% | 78 |
 | $1.08T | 39.1 | +49.6% | 77 |
What is moving NVO
Every story that touched the stock this week, newest first.